Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Jean Marie Connors, M.D.


This page shows the publications co-authored by Jean Connors and Gregory Piazza.
Connection Strength

  1. Update on Guidelines for the Management of Cancer-Associated Thrombosis. Oncologist. 2021 01; 26(1):e24-e40.
    View in: PubMed
    Score: 0.221
  2. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents. TH Open. 2020 Oct; 4(4):e288-e299.
    View in: PubMed
    Score: 0.218
  3. Andexanet Alfa (Andexxa) Formulary Review. Crit Pathw Cardiol. 2019 06; 18(2):66-71.
    View in: PubMed
    Score: 0.199
  4. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. JAMA Cardiol. 2022 07 01; 7(7):747-759.
    View in: PubMed
    Score: 0.061
  5. Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis. Blood Adv. 2021 12 14; 5(23):5283-5289.
    View in: PubMed
    Score: 0.059
  6. Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials. J Thromb Haemost. 2021 12; 19(12):3080-3089.
    View in: PubMed
    Score: 0.058
  7. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 04 20; 77(15):1903-1921.
    View in: PubMed
    Score: 0.056
  8. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. Am J Med. 2020 05; 133 Suppl 1:1-27.
    View in: PubMed
    Score: 0.053
  9. Running thin: implications of a heparin shortage. Lancet. 2020 02 15; 395(10223):534-536.
    View in: PubMed
    Score: 0.052
  10. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy. Am J Med. 2016 Nov; 129(11):1198-1204.
    View in: PubMed
    Score: 0.041
  11. Regulatory, legislative, and policy updates with anticoagulant use. J Thromb Thrombolysis. 2015 Apr; 39(3):273-87.
    View in: PubMed
    Score: 0.037
  12. Medication use evaluation: pharmacist rubric for performance improvement. Pharmacotherapy. 2014 Dec; 34 Suppl 1:5S-13S.
    View in: PubMed
    Score: 0.036
  13. Dabigatran: a review of clinical and pharmacoeconomic evidence. Crit Pathw Cardiol. 2011 Sep; 10(3):117-27.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.